Please assess the completion status of the following clinical trial:

Trial Title: Comparison of the Effects of Two Spinal Cord Stimulation (SCS) Therapies on Subject Reported Pain (BENEFIT-02)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age greater than or equal to 18 years~* Able to understand the nature of the study and provide written informed consent~* Able to read, understand, and speak English~* Willing and able to comply with all study requirements, including all required procedures, phone calls and study visits~* Planned to undergo a commercial SCS trial of standard duration for the treatment of low back and/or leg pain with a commercially available SCS system as prescribed by a physician(s) according to FDA approved indications for use~* Planned utilization of preoperative antibiotics for SCS commercial trial~* Planned placement of two eight-electrode SCS trial leads (or at least one 16- electrode SCS trial lead) using a suitable technique for an extended trial (e.g. tunneling approach of a minimum of 3-4 cm, or buried lead trial) with at least one lead covering the T8 or T9 vertebral level~* Incoming Numerical Rating Scale (NRS) for pain (overall) of at least 6 (collected prior to the commercial trial)~* Passed psychological evaluation~* Negative MRSA screening result~* Negative MSSA screening result or documentation of subsequent decolonization routine if MSSA positive~* For diabetic patients: minimum of one HbA1c test within the last 6 months, with most recent result ≤ 7.5%~Exclusion Criteria:~* Enrolled in any investigational SCS stimulation trial, for which the SCS system is not commercially available~* Presence of any life-threatening, underlying illness separate from their indication for SCS therapy~* Patients reporting pregnancy at the time of enrollment~* Patients with poor compliance for pain management regimen~* Patients currently involved in an active workers compensation claim and/or active litigation related to injury associated with indication for SCS~* Patients with a documented history of substance abuse (narcotics, alcohol, etc.) or substance dependency (other than prescribed) in the 6 months prior to baseline data collection~* Patients with an implanted pacemaker, defibrillator, or other medical contraindications for SCS therapy~* Patients with a medical condition or pain in other area(s), not intended to be treated with SCS, that could interfere with study procedures, accurate pain reporting, and/or confound evaluation of study endpoints, as determined by the investigator~* Patients immunocompromised and/or at high risk for infection~* Patients with morphine equivalent dose \> 120 units~* Patients with documented history of allergic response or sensitivity to material(s) required for the study (e.g. silver impregnated antibacterial dressing, adhesives, titanium, silicone, etc.)~* Patients with a documented history of clostridium difficile

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Therapy A Spinal Cord Stimulation Parameter Set (Type: EXPERIMENTAL): None
- Therapy B Spinal Cord Stimulation Parameter Set (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).